2-GOLD-21-Magazine-Banner-Template-1584-x-396.jpg

THE APRIL  ISSUE
OF GOLD IS HERE!   

Delve into the new issue of GOLD! From the reality of the metaverse, to considering how pharma can restore routine vaccination rates, the latest issue of GOLD considers the latest trends, triumphs and tribulations of the pharmaceutical industry.

April 2022 

Featuring insight from a range of industry experts, this issue explores the key strategies and innovations for patient and customer engagement, the industry’s continued effort to restore normality following COVID-19, and crucial developments in drug development and market access. Topics include:

 

  • The power of gamification

  • The use of RWD and RWE 

  • South Africa as a future pharma power      

  • A captivating conversation with Davidek Herron, Global Head of Digital, Roche 

GOLD-21-Image.jpg

February 2022

With insight from industry experts, this issue features an exploration into the revival of vaccines and the role the pandemic has played in bolstering their R&D infrastructure, considers where biotechs are steering the future of medicine, and investigates how diversity can be turned from idea into action. Topics include: 

  • China’s rise to being a pharma powerhouse

  • Supply chain security

  • Preventative medicine

  • A compelling conversation with Judy Stewart, Senior Vice President and Head of US
    Vaccines, GSK

GOLD-20-Image.jpg

December 2021 

This issue takes a look at the caveats of rapid transformation, the pain of regulatory rejection, and why disparities still exist in rare diseases. Topics include:

 

  • The challenges of drug pricing

  • The evolution of the sales rep 

  • The data revolution      

  • A thought-provoking interview with Tamika Jean-Baptiste, Vice President and Chief Diversity Officer, Amgen

GOLD 19 2021_Page_01.jpg

November 2021

This month’s issue of GOLD features insights from industry thought leaders, shedding light on evolving business strategies within the pharmaceutical industry, solutions to improve vaccine access, and making a difference in terminal diseases. Topics include:

  • Gender parity

  • The drug approval process

  • The accessibility of cell and gene therapies

  • The future of patient centricity

  • A thought-provoking interview with Mary Pinder-Schenk, Vice President and Head, Global Oncology Medical Affairs, Daiichi Sankyo

GOLD 18 2021 Front Cover.jpg

September 2021 

Featuring the insight of industry thought leaders, this issue explores leadership in the new world, the emergence of digital opinion leaders, and how pharma can raise its voice on social justice. Topics include:

 

  • Transitioning from medicine to medical affairs

  • Digital transformation 

  • Shifting workforce values      

  • Drug launches    

  • Building considered campaigns 

  • A captivating interview with Christine Miller, President and Chief Executive Officer, and member of the board, Melinta Therapeutics

GOLD-17-Front-Cover.jpg

June 2021

Featuring the insight of industry thought leaders, this issue explores how the pharmaceutical industry can prepare for the next pandemic, what we can learn from Silicon Valley, and what constitutes a truly great idea. Topics include:

  • Maternal health

  • Digital transformation

  • Tailored marketing

  • Drug launches

  • A thought-provoking interview with Monica Shaw, Executive Vice President, Region EUROPE Plus, LEO Pharma 

GOLD 16 Front Cover FINAL -.jpg

April 2021

Our April issue explores the next phase of the pharmaceutical industry’s COVID-19 response, sustaining innovation throughout recent political changes, and highlights the importance of ensuring all patients and employees feel valued and heard. Topics include:

 

  • Vaccine access

  • Remote campaigns 

  • Patient advocacy groups     

  • Diversity, inclusion, and belonging    

  • A conversation with Bill Sibold, Executive Vice President and Head, Sanofi Genzyme

GOLD-15-Front-Cover-sfw.jpg

February 2021

This issue explores the public perceptions of the pharmaceutical industry over the past year, highlights unmet patient needs, and considers how teams can operate optimally in a virtual environment, featuring the insight of industry thought leaders. Topics include:

  • Drug pricing

  • Cyber-attacks

  • Sexual health

  • Precision medicine

  • A thought-provoking interview with Dr Nick West, Chief Medical Officer, Abbott Vascular 

GOLD 14 Front Cover .jpg

December 2020

This issue explores the transformation the industry has undergone this year, unveiling strategies for further growth, unmet needs still to be fulfilled, and momentum accelerators for us to continue on this trajectory. Topics include:

 

  • Diversity and inclusion  

  • Customer engagement 

  • Virtual education     

  • Health technology   

  • A conversation with Bernie Zeiher, Chief Medical Officer, Astellas Pharma 

GOLD 13 Front Cover.jpg

October 2020

This issue explores the power of partnerships in moving pharma forward during the pandemic, with insights from industry thought leaders. Topics include:

  • Digital therapeutics

  • Diverse clinical trial recruitment

  • Recession resilience

  • Leadership in a crisis

  • A thought-provoking interview with Mace Rothenberg, Chief Medical Officer, Pfizer

GOLD 12 Front Cover.jpg

August 2020

This issue considers the agility of the pharmaceutical industry during the COVID-19 pandemic, as industry leaders are using creativity to have a positive impact on the world. Topics include:

 

  • Creative marketing  

  • Rare disease patients

  • Digital therapeutics    

  • Medication adherence  

  • The forward-thinking outlook of Francesca Wuttke, Chief Digital Officer, Almirall 

GOLD 11 Front Cover.jpg

June 2020

This issue delves into the challenges that are impacting pharma during the COVID-19 pandemic, with insight from industry thought leaders.

Topics include:

  • Virtual events   

  • RWE in marketing 

  • Digital therapeutics     

  • The future of medical affairs   

  • An insightful and inspiring interview with Kristian Hart-Hansen, CEO, LEO Innovation Lab

GOLD 10.jpg

April 2020

This issue tackles some of pharma’s current challenges and provides thought provoking content, with insight from industry thought leaders. Topics include:

 

  • Marrying digital and traditional marketing  

  • Drug launch

  • Storytelling in marketing    

  • Patient loneliness  

  • Powerful insight from Iskra Reic, Executive Vice President, Europe and Canada, AstraZeneca

GOLD 09 FA CEO Approval 22.04.20.jpg

February 2020

This issue explores an array of industry-wide challenges and focusses, with insights from thought leaders from the pharmaceutical industry. Topics include:

 

  • Climate change 

  • Global marketing

  • Retaining recruits    

  • Gender parity  

  • Thought-provoking insights from Dr Terri L. Phillips, Vice President and Head Global Medical Affairs, Merz

GOLD 08 FA 3.jpg

November 2019

This issue includes a wealth of thought-provoking content and insights from thought leaders in the pharmaceutical industry. Topics include:

 

  • Patient happiness

  • Blockchain marketing

  • Precision medicine

  • Clinical trial recruitment

  • Stimulating insights from Isabelle Bocher-Pianka, Chief Patient Affairs, Global Medical Affairs, Ipsen

1 GOLD 07 Cover WU FA2.jpg

August 2019

This issue delivers a host of stimulating content, providing insight from thought leaders in the pharma industry. Some of the topics covered:

 

  • Creative marketing to do good 

  • Leadership in medical affairs 

  • Marketing to Generation Z   

  • A new approach to UX 

  • Engaging insight from Dr Michael Devoy, Chief Medical Officer and Head of Medical Affairs and Pharmacovigilance, Bayer

 06 Front Cover.png

May 2019

This issue brings thought-provoking and challenging content, with insight and opinions from top leaders in the pharma industry. Some of the topics we tackle are:

 

  • Preventative healthcare

  • Mastering the omni-channel experience

  • Carer centricity

  • Unifying the medical affairs function

  • The fascinating outlook of  Kris Sterkens, Company Group Chairman, Janssen, EMEA

GOLD 05 Front Cover lr-01.jpg

February 2019

This issue brings you coverage from some leading pharmaceutical events, and the abundance of topics covered within its pages will ensure leading industry insight on topics such as:

 

  • Digital Opinion Leaders

  • The launch of Speciality Medicines

  • Leadership in Medical Affairs

  • An intuitive and thought-provoking interview with Victoria Elegant, VP and Region Head Medical, Amgen JAPAC

GOLD 04 Front Cover-01.png

November 2018

This issue brings you more words from thought-leaders and award-winning journalists, and provides insight into some of the hottest topics in pharma including:

 

  • Patient collaboration

  • Mastering the digital experience

  • Fighting fake medicines

  • An inspiring interview with Lode Dewulf, Chief Patient Officer, Servier

03_FrontCover_We can do it.png

September 2018

This issue brings you more thought-provoking and challenging content, with insight and opinions from award-winning journalists and thought leaders. Some topics include:

 

  • Marketing to a sceptical generation

  • Measuring the value in medical affairs

  • The top selling drugs and projected figures

  • An engaging interview with Gitte Aabo, President and CEO, LEO Pharma

FrontCover_Issue02_NK-01.png

June 2018

Our first issue brings you the current trends and challenges of the pharma industry, from thought leaders and top industry journalists. Here are some of the topics we tackle:

 

  • Patient centricity

  • Tech disruption

  • The alignment of medical affairs and marketing

  • The largest M&As from the last 7 years

  • A thought-provoking interview with Ulrich Betz, VP of Innovation, Merck KGaA

Gold01_front cover-01.png

1/18

YOU MIGHT ALSO LIKE.. 

People

Setting the stage for a more equitable future
GOLD-21_HBA.jpg

The Healthcare Businesswomen’s Association shares its thoughts and ambitions on diversity, inclusion and equity across the healthcare and life sciences sectors.

Medical Affairs

Fresh clarity on
RWE integration
GOLD 21_RWE.jpg

New FDA guidance provides greater clarity on the use of RWD and RWE. What potential could be unlocked, and how can medical affairs ensure wider adoption?

Tech/Digital

Getting into gamification 
GOLD-21_gamification.jpg

As technology evolves as does the scope for truly addictive gamification. How can companies utilise gameplay for more effective adherence systems, education initiatives and events? 

Never miss an update, subscribe!